Terry, I think Aratana is definitely making the right moves but they've got a big battle to fight to make Galliprant successful. It's been hard to move off the shelves due to the cost. There are plenty non FDA-approved appetite stimulants in the vet world that have been used successfully since before I was alive that are very cheap. I think they will have to be bought out to stand a chance at surviving but that will also depend on how the partnership and sales go I'm sure. Definitely a company to keep an eye on but I think it'll be at least a year or two until things really start moving
News 
Market Data 
Discover 
